Dr. Reddy’s Laboratories CEO Warns Proposed U.S. Tariffs Will Increase Generic Drug Prices
The proposed tariffs on generic drugs by U.S. President Donald Trump are expected to significantly raise prices for patients, according to Erez Israeli, CEO of Dr. Reddy's Laboratories. This move could have broader implications for the generic drug market and its supply chain.